Preliminary Preclinical Data Demonstrates In Vivo Proof-of-Concept for Novel Diabetes Gene Therapy in Type 2 Diabetic Non-Human Primates GPX-002 Rejuvenated Exhausted ...
Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...
Scientists at City of Hope have discovered a gene that plays a surprising role in the development of type 2 diabetes .The ...
Diets, Food Health Benefits, Diseases, Therapy Share and Cite: Menkovska, M. and Raza, S. (2025) Human Gut Microbiome in ...
New evidence shows that remission in type 2 diabetes is attainable through weight loss, surgery, pharmacotherapy, and intensive lifestyle change.
BUENOS AIRES, Dec. 4 (UPI) --Argentine scientists have identified a mechanism that allows pancreatic beta cells, which produce insulin, to become resistant to damage. The finding opens the door to new ...
The deal with a company owned by Embraer gives Beta Technologies an additional source of revenue as it develops its own electric aircraft. By Niraj Chokshi Two companies racing to develop electric ...
Shares of electric aviation startup Beta Technologies took flight Tuesday as the company made its debut on the New York Stock Exchange with an outsized raise of $1 billion and a stock price that ...
BETA Technologies is following a vertically integrated model similar to Tesla’s, starting with niche markets (cargo, defense) before expanding into passenger aviation. BETA's robust order backlog, ...
Identification of type 2 diabetes- and obesity-associated human β-cells using deep transfer learning
This is a useful study that applies deep transfer learning to assign patient-level disease attributes to single cells of T2D and non-diabetic patients, including obese patients. This analysis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback